Evidence map›Paper›PMID 37901236›Full record

ArticleFrontiers in immunology2023

Multi-omics analysis reveals the involvement of origin recognition complex subunit 6 in tumor immune regulation and malignant progression.

Jinfeng Zhu, Qitong Chen, Liyun Zeng, Hongyu Gao, Tong Wu, Yeqing He, Jiachi Xu, Jian Pang, Jing Peng, Yueqiong Deng and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in oncology · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Jinfeng ZhuDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Qitong ChenDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Liyun ZengDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hongyu GaoDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Tong WuDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yeqing HeDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jiachi XuDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jian PangDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jing PengDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yueqiong DengDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yi HanDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Wenjun YiDepartment of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hunan Provincial Center for Disease Control and Prevention · CNSecond Xiangya Hospital of Central South University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Origin recognition complex 6 ( Methods: Unpaired Wilcoxon rank sum and signed rank tests were used to analyze the differences in the expression of Results: Expression of Conclusion: High expression of

Indexed as

Carcinoma, HepatocellularGliomaLiver NeoplasmsOrigin Recognition ComplexHumansImmunosuppressive AgentsMultiomicsTumor MicroenvironmentImmunosuppressive AgentsORC6 protein, humanOrigin Recognition CompleximmunotherapyOrc6pan-cancerprognosistumor microenvironment

Identifiers

PMID37901236
PMCPMC10602784
OpenAlexW4387580609

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.